BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20117176)

  • 1. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
    Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
    Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
    Isaikina Y; Shman T
    Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.
    Vacanti V; Kong E; Suzuki G; Sato K; Canty JM; Lee T
    J Cell Physiol; 2005 Nov; 205(2):194-201. PubMed ID: 15880640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation potential of bone marrow mesenchymal stem cells in duck.
    Li L; Bai X; Gong X; Liu H; Chen L; Guan W; Ma Y
    J Genet Genomics; 2009 Mar; 36(3):133-40. PubMed ID: 19302969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
    Mareschi K; Ferrero I; Rustichelli D; Aschero S; Gammaitoni L; Aglietta M; Madon E; Fagioli F
    J Cell Biochem; 2006 Mar; 97(4):744-54. PubMed ID: 16229018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells.
    Pal R; Hanwate M; Jan M; Totey S
    J Tissue Eng Regen Med; 2009 Mar; 3(3):163-74. PubMed ID: 19229888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.
    Shih DT; Lee DC; Chen SC; Tsai RY; Huang CT; Tsai CC; Shen EY; Chiu WT
    Stem Cells; 2005 Aug; 23(7):1012-20. PubMed ID: 15941858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.
    Ivanova-Todorova E; Bochev I; Mourdjeva M; Dimitrov R; Bukarev D; Kyurkchiev S; Tivchev P; Altunkova I; Kyurkchiev DS
    Immunol Lett; 2009 Sep; 126(1-2):37-42. PubMed ID: 19647021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell.
    Kim DH; Yoo KH; Choi KS; Choi J; Choi SY; Yang SE; Yang YS; Im HJ; Kim KH; Jung HL; Sung KW; Koo HH
    Cytokine; 2005 Jul; 31(2):119-26. PubMed ID: 15919213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
    Gnecchi M; Melo LG
    Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine.
    Tomar GB; Srivastava RK; Gupta N; Barhanpurkar AP; Pote ST; Jhaveri HM; Mishra GC; Wani MR
    Biochem Biophys Res Commun; 2010 Mar; 393(3):377-83. PubMed ID: 20138833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.